Minor Ischemic Stroke Completed Phase 2 Trials for Dabigatran etexilate (DB06695)

IndicationStatusPhase
DBCOND0061945 (Minor Ischemic Stroke)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02295826Dabigatran Following Transient Ischemic Attack and Minor StrokeTreatment
NCT01769703Dabigatran Treatment Following Transient Ischemic Attack and Minor StrokeTreatment